(A) Progression free survival for the two groups of patients, those that had previously received 5-FU or xeloda, and those that had received at least one oxaliplatin or irinotecan containing regimen
收藏数据链接：
官方服务：
资源简介：
<b>Copyright information:</b>Taken from "A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy"BMC Cancer 2005;5():132-132.Published online 15 Oct 2005PMCID:PMC1274303.Copyright � 2005 Lim et al; licensee BioMed Central Ltd. (B) Overall survival for the two groups of patients, those that had previously received 5-FU or xeloda, and those that had received at least one oxaliplatin or irinotecan containing regimen.
提供机构：
figshare创建时间：
2016-01-11
